Intervet to divest part of feed additives business
Akzo Nobel's animal healthcare business, Intervet, has agreed to divest some of its feed additives activities to Bulgarian company Biovet®. Both parties have agreed not to disclose financial details. Scheduled to be finalized on July 31, the agreement-which is subject to various corporate and governmental approvals-concerns the sale of Intervet's Sacox®, Salocin®, Flavomycin®, Gainpro®, Hostazym® and Stenorol® products.
"These activities no longer fit in with our core business operations and have become distanced from Intervet's portfolio from a strategic perspective," explained Akzo Nobel Board Member Toon Wilderbeek.
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.